Phase II case-control trial initiated for four types of terminal cancers

[News]

The Alexandrov National Cancer Centre begins phase II case-control clinical trial of its immuno-oncology agent, Elenagen.

More... (https://www.news-medical.net/news/20200107/Phase-II-case-control-trial-initiated-in-four-types-of-terminal-cancers.aspx)